Bicycle Therapeutics (BCYC) Current Leases (2019 - 2025)
Bicycle Therapeutics (BCYC) posted Current Leases of $205000.0 for Q4 2025, up 3.02% on a QoQ basis from $199000.0 in Q2 2025, and down 96.15% year-over-year from $5.3 million in Q4 2024.
Bicycle Therapeutics (BCYC) Current Leases (2019 - 2025) Analysis & Trends
Bicycle Therapeutics' Current Leases history runs 7 years deep, the most recent figure standing at $205000.0 for Q4 2025.
- Quarterly Current Leases fell 96.15% year-over-year to $205000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $205000.0 (down 96.15% YoY) and the FY2025 annual result came in at $205000.0, down 96.15% from the prior year.
- Current Leases was $205000.0 for Q4 2025 at Bicycle Therapeutics, up from $199000.0 in the prior quarter.
- Across five years, Current Leases topped out at $5.4 million in Q3 2024 and bottomed at $184000.0 in Q1 2025.
- A 5-year average of $3.0 million and a median of $3.0 million in 2022 frame the typical range for Current Leases.
- Annual changes were most pronounced in 2022 — Current Leases surged 323.16% — and 2025, when it sank 96.3%.
- Bicycle Therapeutics' Current Leases stood at $2.4 million in 2021, then surged by 31.14% to $3.1 million in 2022, then soared by 56.03% to $4.9 million in 2023, then rose by 9.27% to $5.3 million in 2024, then plunged by 96.15% to $205000.0 in 2025.
- Business Quant data shows BCYC's Current Leases at $205000.0 in Q4 2025, $199000.0 in Q2 2025, and $184000.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 531,233.95 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 20.58 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 872,589.03 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 720.00 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 11.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 16.61 Mn |
| 10 | Bicycle Therapeutics | 289.88 Mn | 289.88 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 205,000.00 |
| Jun 30, 2025 | 199,000.00 |
| Mar 31, 2025 | 184,000.00 |
| Dec 31, 2024 | 5.33 Mn |
| Sep 30, 2024 | 5.37 Mn |
| Jun 30, 2024 | 5.10 Mn |
| Mar 31, 2024 | 4.97 Mn |
| Dec 31, 2023 | 4.88 Mn |
| Sep 30, 2023 | 4.66 Mn |
| Jun 30, 2023 | 4.68 Mn |
| Mar 31, 2023 | 4.66 Mn |
| Dec 31, 2022 | 3.13 Mn |
| Sep 30, 2022 | 2.81 Mn |
| Jun 30, 2022 | 2.91 Mn |
| Mar 31, 2022 | 3.00 Mn |
| Dec 31, 2021 | 2.38 Mn |
| Sep 30, 2021 | 826,000.00 |
| Jun 30, 2021 | 773,000.00 |
| Mar 31, 2021 | 708,000.00 |
| Dec 31, 2020 | 844,000.00 |